2019
DOI: 10.1016/j.parkreldis.2019.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Underestimated disease prevalence and severe phenotypes in patients with biallelic variants: A cohort study of primary familial brain calcification from China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
15
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 25 publications
0
15
0
Order By: Relevance
“…Overall minimal prevalence of PFBC is estimated to be 2.1 to 6.6 per 1,000. 1,2 Affected individuals could remain asymptomatic throughout their lifetime or present with a wide spectrum of neurological and psychiatric symptoms. Since the finding of SLC20A2, 3 the first PFBC-associated gene, mutations in three other genes, PDGFRB, 4 PDGFB, 5 and XPR1, 6 have been consecutively identified to be responsible for autosomal-dominant PFBC (AD-PFBC).…”
mentioning
confidence: 99%
“…Overall minimal prevalence of PFBC is estimated to be 2.1 to 6.6 per 1,000. 1,2 Affected individuals could remain asymptomatic throughout their lifetime or present with a wide spectrum of neurological and psychiatric symptoms. Since the finding of SLC20A2, 3 the first PFBC-associated gene, mutations in three other genes, PDGFRB, 4 PDGFB, 5 and XPR1, 6 have been consecutively identified to be responsible for autosomal-dominant PFBC (AD-PFBC).…”
mentioning
confidence: 99%
“…MSA is fatal, with median survival from onset to death of 6-10 years and median time from diagnosis to death of approximately 3 years. 1,2 Clinical and objective autonomic features such as urinary incontinence, falls, older age, greater degree of autonomic failure, and male sex have been associated with poor survival. [1][2][3] Vitamin B12 has been shown to inhibit α-synuclein fibrillation and cytotoxicity in neuronal cultures and cytotoxicity assays, as well as alleviate dopaminergic dysfunction in mouse models of Parkinson's disease, suggesting a potential disease-modifying effect.…”
Section: Supporting Datamentioning
confidence: 99%
“…1,2 Clinical and objective autonomic features such as urinary incontinence, falls, older age, greater degree of autonomic failure, and male sex have been associated with poor survival. [1][2][3] Vitamin B12 has been shown to inhibit α-synuclein fibrillation and cytotoxicity in neuronal cultures and cytotoxicity assays, as well as alleviate dopaminergic dysfunction in mouse models of Parkinson's disease, suggesting a potential disease-modifying effect. 4,5 Allosteric modulation of leucine-rich repeat kinase 2 (LRRK2) is thought to be one of the main neuroprotective mechanisms of vitamin B12.…”
Section: Supporting Datamentioning
confidence: 99%
See 1 more Smart Citation
“…PFBC is a clinically and genetically heterogenous disease caused by mutations in at least in five genes – MYORG, PDGFB, PDGFRB, SLC20A2 and XPR1 2125 . Of note, recent studies have estimated the minimal prevalence of PFBC ranges from 4-6 p. 10,000, depending of the causative gene mutation, thus suggesting that PFBC is not a rare disorder and is likely underdiagnosed 26, 27 . In addition, basal ganglia calcification is a common radiological finding, estimated in up to 20% of patients undergoing CT imaging 28, 29 .…”
Section: Introductionmentioning
confidence: 99%